Hui Deng

机构：Shihezi University, Oklahoma State Department of Health, Xiamen University, Chengdu Medical College, Sichuan University, Frontier Hospital, West China Hospital of Sichuan University, Precision for Medicine (United States), Precision Research (United States), Beijing Shijitan Hospital, Sichuan University of Science and Engineering, South China University of Technology · ORCID：0000-0003-0899-4188

发表论文 99 篇 · 总被引 2283 次 · h-index 24

代表论文

• Therapeutic potential of targeting polo-like kinase 4 (2024 · European Journal of Medicinal Chemistry · 被引 22)
• Identification of Hedyotis diffusa Willd-specific mRNA–miRNA–lncRNA network in rheumatoid arthritis based on network pharmacology, bioinformatics analysis, and experimental verification (2024 · Scientific Reports · 被引 17)
• Concentration-Bias-Free Discrimination of Single Nucleotide Variants Using Isothermal Nucleic Acid Amplification and Mismatch-Guided DNA Assembly (2025 · Analytical Chemistry · 被引 13)
• Regulatory T cells in neurological disorders and tissue regeneration: Mechanisms of action and therapeutic potentials (2025 · Neural Regeneration Research · 被引 12)
• Structure–Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors (2024 · Journal of Medicinal Chemistry · 被引 7)
• Image-Based Phenotypic Profiling Enables Rapid and Accurate Assessment of EGFR-Activating Mutations in Tissues from Lung Cancer Patients (2025 · Journal of the American Chemical Society · 被引 5)